Latest Asx Market Updates News

Tuas Limited has raised A$385 million through an institutional placement at $5.51 per share to fund its acquisition of M1, while also initiating a share purchase plan to raise an additional A$50 million from existing shareholders.

Donaco International Limited’s shares have been suspended from trading on the ASX following court approval of its acquisition by On Nut Road Limited. This marks a significant step in the company’s transition under new ownership.

Donaco International’s acquisition scheme by On Nut Road Limited has been legally approved, triggering an imminent trading suspension and a cash payout to shareholders.

Donaco International Limited shareholders have overwhelmingly approved the proposed acquisition by On Nut Road Limited, clearing a critical hurdle in the takeover process. The scheme now awaits final court approval before implementation.

Forrestania Resources Limited has had its trading suspension lifted following the announcement of a proposed acquisition, signaling a pivotal moment for the mining explorer.

Classic Minerals Limited has secured strategic tenements adjoining its Forrestania Gold Project and appointed a drilling contractor under a novel drill-for-equity agreement, while navigating ongoing legal disputes and ASX suspension.

Ramelius Resources has completed its acquisition of Spartan Resources, issuing new shares and cash to Spartan shareholders and reshaping its board as it integrates the Dalgaranga asset.

Ramelius Resources has finalized its acquisition of Spartan Resources, issuing new shares and cash to Spartan shareholders while expanding its board and asset portfolio. This move aims to accelerate Ramelius' growth toward becoming a half-million ounce gold producer within five years.

MedAdvisor Solutions reported a 16.6% revenue decline in 4Q FY25, driven by US market challenges, while completing the sale of its ANZ business and initiating a strategic review of its US operations.

Winchester Energy Limited has resumed trading on the ASX following confirmation that it now meets director requirements under the Corporations Act. This development ends a trading suspension tied to governance compliance.

Doctor Care Anywhere has reported a landmark positive operating and investing cash inflow in Q2 2025, alongside modest consultation growth and strategic service expansion. The company reiterates its ambitious revenue and profitability targets amid ongoing cost transformation.

AVJennings Limited shares will halt trading following court approval of a takeover scheme by PM Nominees C Pty Ltd, marking a pivotal shift for the property developer.